Abstract
In the central nervous system, dopamine is known to play a critical role in motor and cognitive functions. Although the cerebellum plays a role in the control of movement and posture and in cognitive functions, it has not been considered to be a dopaminergic region and the dopamine present was thought to represent a precursor of noradrenaline. However, recent evidence suggests that in the cerebellum there is a small dopaminergic element, whose properties are similar to the well characterized system of striatum. In order to better understand the functional role of this system and to delineate its specific interactions within the cerebellum, the distribution and properties of dopamine transporter (DAT) in the cerebellum ofreeler andPurkinje cell degeneration (Nna1 pcd) mutant mice, which are characterized by severe loss of different cell populations and abnormalities in synapse formation, have been studied. Kinetic studies revealed that [3H] dopamine is transported into cerebellar synaptosomes prepared from normal mice with affinities similar to that into striatal synaptosomes but with much lower maximal velocities. Inreeler cerebellar synaptosomes the number of transport sites is significantly reduced. InNna1 pcd cerebellar synaptosomes the kinetic properties of transport of [3H] dopamine are similar to the normal. However,in vitro quantitative DAT autoradiography revealed a significantly increased binding in cerebellar nuclei, a decreased binding in molecular layer and an unaltered binding in the granule cell layer. These observations confirm a dopaminergic innervation of the cerebellum and contribute to our understanding of the intracerebellar distribution of the dopaminergic system.
Similar content being viewed by others
References
Kizer JS, Palkovits M, Brownstein MJ. The projections of the A8, A9 and A10 dopaminergic cell bodies: Evidence for a nigral-hypothalamic-median eminence dopaminergic pathway. Brain Res. 1976;108:363–70.
Panagopoulos NT, Papadopoulos GC, Matsokis NA. Dopaminergic innervation and binding in rat cerebellum. Neurosci Lett. 1991;130:208–12.
Ikai Y, Takada M, Shinonaga Y, Mizuno N. Dopaminergic and non dopaminergic neurons in the ventral tegmental area of the rat project, respectively, to the cerebellar cortex and deep cerebellar nuclei. Neuroscience. 1992;51:719–28.
Melchitzky DS, Lewis DA. Tyrosine Hydroxylase-and dopamine transporter-immunoreactive axons in the primate cerebellum. Evidence for lobular-and laminarspecific dopamine innervation. Neuropsychopharmacol. 2000;22:466–72.
Efthimiopoulos S, Giompres P, Valcana T. Kinetics of dopamine and noradrenaline transport in synaptosomes from cerebellum, striatum and frontal cortex of normal and reeler mice. J Neurosci Res. 1991;29:510–9.
Dethy S, Manto M, Bastianelli E, Gangji V, Laute MA, Goldman S, Hildebrand J. Cerebellar spongiform degeneration induced by acute lithium intoxication in the rat. Neurosci Lett. 1997;224:25–8.
Boyson SJ, McGonigle P, Mollinof PB. Quantitative auto-radiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci. 1986;6:3177–88.
Dubois A, Savasta M, Curet O, Scatton B. Autoradiographic distribution of the D1 agonist [3H]SKF38393 in the rat brain and spinal cord. Comparison with the distribution of D2 receptors. Neuroscience. 1986;19:125–37.
Camps M, Kelly PH, Palacios JM. Autoradiographic localization of dopamine D1and D2 receptors in brain of several mammalian species. J Neural Trans. 1990;80:105–27.
Panagopoulos NT, Matsokis NA, Valkana T. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations. J Neurosci Res. 1993;35:409–506.
Khan ZU, Gutierrez A, Martin R, Penafiel A, Rivera A, de la Calle A. Differential regional and cellular distribution of dopamine D2-like receptors: An immunocytochemical study of subtype-specific antibodies in rat and human brain. J Comp Neurol. 1998;402:353–71.
Barili P, Bronzetti E, Ricci A, Zaccheo D, Amenta F. Microanatomical localization of dopamine receptor protein immunoreactivity in the rat cerebellar cortex. Brain Res. 2000;854:130–8.
Mansur A, Meador-Woodruff JH, Zhou QY, Civelli O, Akil H, Watson SJ. A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiography and in situ hybridization techniques. Neuroscience. 1991;45:359–71.
Mengod G, Villaro MT, Landwehrmeyer GB, et al. Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain. Neurochem Int. 1992;20(Suppl.):33S-43S.
Laurier LG, O’Dowd BF, George SR. Heterogeneous tissue-specific transcription of dopamine receptor subtype messenger RNA in rat brain. Brain Res Mol Brain Res. 1994;25:344–50.
Mariani J, Crepel F, Mikoshiba K, Changeux JP, Sotelo C. Anatomical, physiological and biochemical studies of the cerebellum from Reeler mutant mouse. Philos Trans R Soc Lond Biol. 1977;281:1–28.
Caviness VS jr, Rakic P. Mechanisms of cortical development. A view from mutations in mice. Annu Rev Neurosci. 1978;1:297–326.
Goffinet AM. Events governing organization of postmigratory neurons: Studies on brain development in normal and reeler mice. Brain Res. 1984;319:261–96.
D’Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature. 1995;374:719–23.
Miyata T, Nakajima K, Aruga J, et al. Distribution of the reeler gene-related antigen in the developing cerebellum: An immunohistochemical study with an allogenic antibody CR-50 on normal and reeler mice. J Comp Neurol. 1996;372:215–28.
Schiffmann SN, Bernier B, Goffinet AM. Reelin mRNA expression during mouse brain development. Eur J Neurosci. 1997;9:1055–71.
Landis SC, Mullen RJ. The development and degeneration of Purkinje cells inpcd mutant mice. J Comp Neurol. 1978;177:125–44.
Roffler-Tarlov S, Beart PM, O’Gorman S, Sidman RL. Neurochemical and morphological consequences of axon terminal degeneration in cerebellar deep nuclei of mice with inherited Purkinje cell degeneration. Brain Res. 1979;168:75–95.
Gheti B, Norton J, Triarchou LC. Nerve cell atrophy and loss in the inferior olivary complex of ‘Purkinje cell degeneration’ mutant mice. J Comp Neurol. 1987;260:409–22.
LeMarec N, Lalonde R. Treadmill performance of mice with cerebellar lesions: 1. Purkinje cell degeneration mutant mice. Behav Neurosci. 1998;112:225–32.
LeMarec N, Lalonde R. Sensorimotor learning and retention during equilibrium tests in Purkinje cell degeneration mutant mice. Brain Res. 1997;768:310–6.
Goodlett RC, Hamre KM, West JR. Dissociation of spatial navigation and visual guidance performance in Purkinje cell degeneration (pcd) mutant mice. Behav Brain Res. 1992;47:129–41.
Fernandez-Gonzalez A, La Spanda AR, Treadaway J, et al.Purkinje cell degeneration (pcd) phenotypes caused by mutations in the axotomy-induced gene,Nna1 Science. 2002;295:1904–6.
Torres GE, Gainetdinov RR, Caron MG. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci. 2003;4:13–25.
Delis F, Mitsacos A, Giompres P. Dopamine receptor and transporter levels are altered in the brain ofPurkinje cell degeneration mutant mice. Neuroscience. 2004;225:255–68.
Ballmaier M, Zoli M, Leo G, Agnati LF, Spano P. Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: An emerging animalbased model of schizophrenia. Eur J Neurosci. 2002;15:1197–205.
Nishikawa S, Goto S, Yamada K, Hamasaki T, Ushio Y. Lack of Reelin causes malpositioning of nigral dopaminergic neurons: evidence from comparison of normal andreln Tl mutant mice. J Comp Neurol. 2003;461:166–73.
Zanisher N, Doolen S. Chronic and acute regulation of Na+/Cl--dependent neurotransmitter transporters: Drugs, substrates, presynaptic receptors and signaling systems. Pharmacol Ther. 2001;92:21–55.
Batini C, Compoint C, Buisseret-Delmas C, Daniel H, Guegan M. Cerebellar nuclei and the nucleocortical projections in the rat: retrograde tracing coupled to GABA and glutamate immunohistochemistry. J Comp Neurol. 1992;315:74–84.
Snider RS, Maiti A, Snider SR. Cerebellar pathways to ventral midbrain and nigra. Exp Neurol. 1976;53:714–28.
Perciavalle V, Berretta F, Raffaelle R. Projections from the intracerebellar nuclei to the ventral midbrain tegmentum in the rat. Neuroscience. 1989;29:109–19.
Rice ME, Cragg SJ, Greenfield SA. Characteristics of electrically-evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro. J Neurophysiol. 1997;77:853–62.
Hurley MJ, Mash DC, Jener P. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson’s disease examined by RT-PCR. Eur J Neurosci. 2003;18:2668–72.
Takada M, Sugimoto T, Hattori T. MPTP neurotoxicity to cerebellar Purkinje cells in mice. Neurosci Lett. 1993;150:49–52.
Le Marek N, Hebert C, Amdiss F, Botez MI, Reader TA. Regional distribution of 5-HT transporters in the brain of wild type and ‘Purkinje cell degeneration’ mutant mice: A quantitative autoradiographic study with [3H]citalopram. J Chem Neuroanat. 1998;15:155–71.
Strazielle C, Lalonde R, Hebert C, Reader TA. Regional brain distribution of noradrenaline uptake studies, and of α1-, α2- and ß-adrenergic receptors inpcd mutant mice: a quantitative autoradiographic study. J Neurosci. 1999;94:287–304.
Wise RA. Catecholamine theories of reward: a critical review. Brain Res. 1978;152:215–47.
Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 1987;237:1219–23.
Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev. 1987;94:469–92.
Letchworth SR, Sexton T, Childers SR, Vrana KE, Vaughan RA, Davies HM, Porrino LJ. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration. J Neurochem. 1999;73:1982–9.
Wang H-Y, Runyan S, Yadin E, Friedman E. Prenatal exposure to cocaine selectively reduces D1 dopamine receptor-mediated activation of striatal Gs proteins. J Pharmacol Exp Ther. 1995;273:492–8.
Friedman E, Yadin E, Wang H-Y. Effect of prenatal cocaine on dopamine receptor-G protein coupling in mesocortical regions of the rabbit brain. Neuroscience. 1996;70:739–47.
Tilakaratne N, Cai GP, Friedman E. Attenuation of cocaine-induced genomic and functional responses in prenatal cocaine-exposed rabbits. Pharmacol Biochem Behav. 2001;69:225–32.
Zhen X, Torres C, Wang H-Y, Friedman E. Prenatal exposure to cocaine disrupts D1A dopamine receptor function via selective inhibition of protein phosphatase I pathway in rabbit frontal cortex. J Neurosci. 2001;21:9160–7.
Jones LB, Stanwood GD, Reinoso BS, Washington RA, Wang H-Y, Friedman E, Levitt P. In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons. J Neurosci. 2000;20:4606–14.
Kosofsky BE, Wilkins AS, Gressens P, Evrard P. Transplacental cocaine exposure — a mouse model demonstrating neuroanatomic and behavioral abnormalities. J Child Neurol. 1994;9:234–41.
Barabam SC, Wenzel HJ, Castro PA, Schwartzkroin PA. Hippocampal dysplasia in rats exposed to cocaine in utero. Brain Res Dev Brain Res. 1999;117:213–7.
Lidow MS, Song ZM. Primates exposed to cocaine in utero display reduced density and number of cerebral cortical neurons. J Comp Neurol. 2001;435:263–75.
Klitenick MA, Tham CS, Fibiger HC. Cocaine and d-amphetamine increase c-fos expression in the rat cerebellum. Synapse. 1995;19:29–36.
Couceyro P, Pollock KM, Drews K, Douglass J. Cocaine differentially regulates activator protein-1 mRNA levels and DNA-binding complexes in the rat striatum and cerebellum. Mol Pharmacol. 1994;46:667–76.
Bortollozi A, Duffard R, Antonelli M, Evangelista De Buffard AM. Increased sensitivity in dopamine D2-like brain receptors from 2,4-dichlorophenoxyacetic acid (2,4-D)-exposed and amphetamine-challenged rats. Ann NY Acad Sci. 2002;965:314–23.
Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 1996;379:606–12.
Jaber M, Dumartin B, Sagne C, Haycock JW, Roubert C, Giros B, Bloch B, Caron MG. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur J Neurosci. 1999;11:3499–511.
Fauchey V, Jaber M, Bloch B, Le Moine C. Dopamine control of striatal gene expression during development: Relevance to knockout mice for the dopamine transporter. Eur J Neurosci. 2000;12:3415–25.
Dumartin B, Jaber M, Gonon F, Caron MG, Giros B, Bloch B. Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice. Proc Natl Acad Sci USA. 2000;97:1879–84.
Zhou QY, Palmiter RD. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell. 1995;83:1197–209.
Kim DS, Szczypka MS, Palmiter RD. Dopamine-deficient mice are hypersensitive to dopamine receptor agonists. J Neurosci. 2000;20:4405–13.
Thomas SA, Marck BT, Palmiter RD, Matsumoto AM. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J Neurochem. 1998;70:2468–76.
Jin SH, Kim HJT, Harris DC, Thomas SA. Postnatal development of the cerebellum and the CNS adrenergic system is independent of norepinephrine and epinephrine. J Comp Neurol. 2004;477:300–9.
Robain O, Lanfumey L, Adrien J, Farkas E. Developmental changes in the cerebellar cortex after locus ceruleus lesion with 6-hydroxydopamine in the rat. Exp Neurol. 1985;88:150–64.
Podkletnova I, Rothstein JD, Helen P, Alho H. Microglial response to the neurotoxicity of 6-hydroxydopamine in neonatal rat cerebellum. Int J Dev Neurosci. 2001;19:47–52.
Podkletnova I, Alho H, Makela R, Luddens H, Helen P, Korpi ER. Neonatal 6-hydroxydopamine treatment affects GABAA receptor subunit expression during postnatal development of the rat cerebellum. Int J Dev Neurosci. 2001;18:565–72.
Wagner JP, Seidler RJ, Lappi SE, McCook EC, Slotkin TA. Role of presynaptic input in the ontogeny of adrenergic cell signaling in rat brain: Beta receptors adenylate cyclase and c-fos protooncogene expression. J Pharmacol Exp Ther. 1995;273:415–26.
Doya K. What are the computations of the cerebellum, the basal ganglia and the cerebral cortex? Neural Netw. 1999;12:961–74.
Sclultz W. Predictive reward signal of dopamine neurons. J Physiol. 1998;80:1–27.
Schweighofer N, Doya K, Kuroda S. Cerebellar aminergic neuromodulation: Towards a functional understanding. Brain Res Brain Res Rev. 2004;44:103–16.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giompres, P., Delis, F. Dopamine transporters in the cerebellum of mutant mice. Cerebellum 4, 105–111 (2005). https://doi.org/10.1080/14734220510007851
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/14734220510007851